Wells Fargo & Company Femasys Inc Call Options Transaction History
Wells Fargo & Company
- $433 Billion
- Q4 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding FEMY
# of Institutions
29Shares Held
2.34MCall Options Held
0Put Options Held
0-
Vanguard Group Inc Valley Forge, PA826KShares$1.3 Million0.0% of portfolio
-
Cm Management, LLC425KShares$667,2500.43% of portfolio
-
Clear Creek Financial Management, LLC256KShares$402,5020.03% of portfolio
-
Geode Capital Management, LLC Boston, MA216KShares$339,3770.0% of portfolio
-
Northern Trust Corp Chicago, IL126KShares$197,9700.0% of portfolio
About FEMASYS INC
- Ticker FEMY
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 11,813,600
- Market Cap $18.5M
- Description
- Femasys Inc., a biomedical company, focuses on women's healthcare market in the United States. The company develops permanent birth control solutions, such as FemBloc and FemChec; FemaSeed, an artificial insemination solution; FemCerv, a biopsy device for endocervical curettage; and FemEMB, a product candidate for endometrial sampling in support...